160 related articles for article (PubMed ID: 7916008)
1. Biological determinants and risk factors for tardive dyskinesia in schizophrenia.
Sandyk R
Int J Neurosci; 1993; 69(1-4):35-51. PubMed ID: 7916008
[TBL] [Abstract][Full Text] [Related]
2. Tardive dyskinesia outcomes: clinical and pharmacologic correlates of remission and persistence.
Cavallaro R; Regazzetti MG; Mundo E; Brancato V; Smeraldi E
Neuropsychopharmacology; 1993 May; 8(3):233-9. PubMed ID: 8099483
[TBL] [Abstract][Full Text] [Related]
3. Increased tardive dyskinesia in alcohol-abusing schizophrenic patients.
Dixon L; Weiden PJ; Haas G; Sweeney J; Frances AJ
Compr Psychiatry; 1992; 33(2):121-2. PubMed ID: 1347498
[TBL] [Abstract][Full Text] [Related]
4. Tardive dyskinesia in the mentally retarded: comparison of prevalence, risk factors and topography with a schizophrenic population.
Cohen S; Khan A; Zheng Y; Chiles J
Acta Psychiatr Scand; 1991 Mar; 83(3):234-7. PubMed ID: 1674398
[TBL] [Abstract][Full Text] [Related]
5. Tardive dyskinesia and type II schizophrenia.
Davis EJ; Borde M; Sharma LN
Br J Psychiatry; 1992 Feb; 160():253-6. PubMed ID: 1347240
[TBL] [Abstract][Full Text] [Related]
6. Cognitive impairment in tardive dyskinesia.
Wegner JT; Kane JM; Weinhold P; Woerner M; Kinon B; Lieberman J
Psychiatry Res; 1985 Dec; 16(4):331-7. PubMed ID: 2868476
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic reduction and/or cessation and neuroleptics as specific treatments for tardive dyskinesia.
McGrath JJ; Soares KV
Cochrane Database Syst Rev; 2000; (2):CD000459. PubMed ID: 10796546
[TBL] [Abstract][Full Text] [Related]
8. Prevalence and risk factors associated with tardive dyskinesia among Indian patients with schizophrenia.
Achalia RM; Chaturvedi SK; Desai G; Rao GN; Prakash O
Asian J Psychiatr; 2014 Jun; 9():31-5. PubMed ID: 24813033
[TBL] [Abstract][Full Text] [Related]
9. Clozapine-induced tardive dyskinesia in schizophrenic patients taking clozapine as a first-line antipsychotic drug.
Li CR; Chung YC; Park TW; Yang JC; Kim KW; Lee KH; Hwang IK
World J Biol Psychiatry; 2009; 10(4 Pt 3):919-24. PubMed ID: 19995222
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and risk factors for tardive dyskinesia: a study in an Italian population of chronic schizophrenics.
Altamura AC; Cavallaro R; Regazzetti MG
Eur Arch Psychiatry Clin Neurosci; 1990; 240(1):9-12. PubMed ID: 1979540
[TBL] [Abstract][Full Text] [Related]
11. Tardive dyskinesia in outpatients on depot phenothiazine.
Neehall J
West Indian Med J; 1989 Dec; 38(4):228-33. PubMed ID: 2576166
[TBL] [Abstract][Full Text] [Related]
12. The current prevalence and factors associated with tardive dyskinesia among Filipino schizophrenic patients.
Go CL; Rosales RL; Caraos RJ; Fernandez HH
Parkinsonism Relat Disord; 2009 Nov; 15(9):655-9. PubMed ID: 19346155
[TBL] [Abstract][Full Text] [Related]
13. Blood superoxide dismutase level in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.
Zhang XY; Zhou DF; Cao LY; Chen DC; Zhu FY; Wu GY
Schizophr Res; 2003 Aug; 62(3):245-50. PubMed ID: 12837521
[TBL] [Abstract][Full Text] [Related]
14. The current status of tardive dyskinesia.
Sachdev PS
Aust N Z J Psychiatry; 2000 Jun; 34(3):355-69. PubMed ID: 10881961
[TBL] [Abstract][Full Text] [Related]
15. Clinical correlates of tardive dyskinesia in schizophrenia: baseline data from the CATIE schizophrenia trial.
Miller DD; McEvoy JP; Davis SM; Caroff SN; Saltz BL; Chakos MH; Swartz MS; Keefe RS; Rosenheck RA; Stroup TS; Lieberman JA
Schizophr Res; 2005 Dec; 80(1):33-43. PubMed ID: 16171976
[TBL] [Abstract][Full Text] [Related]
16. An assessment of emergent tardive dyskinesia and existing dyskinesia in patients receiving long-acting, injectable risperidone: results from a long-term study.
Gharabawi GM; Bossie CA; Zhu Y; Mao L; Lasser RA
Schizophr Res; 2005 Sep; 77(2-3):129-39. PubMed ID: 15913962
[TBL] [Abstract][Full Text] [Related]
17. Association of CYP2D6 and CYP1A2 gene polymorphism with tardive dyskinesia in Chinese schizophrenic patients.
Fu Y; Fan CH; Deng HH; Hu SH; Lv DP; Li LH; Wang JJ; Lu XQ
Acta Pharmacol Sin; 2006 Mar; 27(3):328-32. PubMed ID: 16490169
[TBL] [Abstract][Full Text] [Related]
18. Neuroleptic withdrawal in treatment-resistant patients with schizophrenia: tardive dyskinesia is not associated with supersensitive psychosis.
Apud JA; Egan MF; Wyatt RJ
Schizophr Res; 2003 Sep; 63(1-2):151-60. PubMed ID: 12892869
[TBL] [Abstract][Full Text] [Related]
19. Tardive dyskinesia in schizophrenics under 60 years of age.
Kolakowska T; Williams AO; Ardern M; Reveley MA
Biol Psychiatry; 1986 Feb; 21(2):161-9. PubMed ID: 2868762
[TBL] [Abstract][Full Text] [Related]
20. Decreased plasma brain-derived neurotrophic factor levels in schizophrenic patients with tardive dyskinesia: association with dyskinetic movements.
Tan YL; Zhou DF; Zhang XY
Schizophr Res; 2005 May; 74(2-3):263-70. PubMed ID: 15722005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
